Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2011
Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity
Philipp A Lang, Karl S Lang, Haifeng C Xu, et al.
The Journal of Allergy and Clinical Immunology
|
December 31, 2013
Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotype
Mike Recher, Marja-Liisa Karjalainen-Lindsberg, Mikael Lindlöf, et al.
Blood
|
November 1, 2011
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo
Mike Recher, Lucinda J Berglund, Danielle T Avery, et al.
Journal of Virology
|
February 13, 2015
Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection
Haifeng C Xu, Jun Huang, Vishal Khairnar, et al.
Journal of Clinical Immunology
|
August 22, 2017
Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency
Florian A Marquardsen, Fabian Baldin, Florian Wunderer, et al.
Nature Communications
|
February 19, 2015
CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production
Vishal Khairnar, Vikas Duhan, Sathish Kumar Maney, et al.
Nature Immunology
|
March 25, 2022
Author Correction: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation
Haifa H Jabara, Douglas R McDonald, Erin Janssen, et al.
Nature Immunology
|
May 15, 2012
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation
Haifa H Jabara, Douglas R McDonald, Erin Janssen, et al.
The Journal of Allergy and Clinical Immunology
|
December 3, 2016
Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
Alexander A Navarini, Petr Hruz, Christoph T Berger, et al.
JAMA Oncology
|
April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
Fiamma Berner, David Bomze, Stefan Diem, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2011
Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity
Philipp A Lang, Karl S Lang, Haifeng C Xu, et al.
The Journal of Allergy and Clinical Immunology
|
December 31, 2013
Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotype
Mike Recher, Marja-Liisa Karjalainen-Lindsberg, Mikael Lindlöf, et al.
Blood
|
November 1, 2011
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo
Mike Recher, Lucinda J Berglund, Danielle T Avery, et al.
Journal of Virology
|
February 13, 2015
Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection
Haifeng C Xu, Jun Huang, Vishal Khairnar, et al.
Journal of Clinical Immunology
|
August 22, 2017
Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency
Florian A Marquardsen, Fabian Baldin, Florian Wunderer, et al.
Nature Communications
|
February 19, 2015
CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production
Vishal Khairnar, Vikas Duhan, Sathish Kumar Maney, et al.
Nature Immunology
|
March 25, 2022
Author Correction: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation
Haifa H Jabara, Douglas R McDonald, Erin Janssen, et al.
Nature Immunology
|
May 15, 2012
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation
Haifa H Jabara, Douglas R McDonald, Erin Janssen, et al.
The Journal of Allergy and Clinical Immunology
|
December 3, 2016
Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
Alexander A Navarini, Petr Hruz, Christoph T Berger, et al.
JAMA Oncology
|
April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
Fiamma Berner, David Bomze, Stefan Diem, et al.
Page
of 13